Follow-The-Filings

Security · featured owners

VTRS Viatris Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 5.1%
  • $1.4B
  • 3 add 1 reduce 1 exit

VTRS (Viatris Inc.) is held in 4 featured 13F books as of 2026 Q2. Christopher Davis - Davis Selected Advisers is the largest tracked holder by portfolio weight (5.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 5.1% (Christopher Davis - Davis Selected Advisers) · not free-float ownership

  1. Christopher Davis reduce 5.1%
  2. Glenview Capital Management add 2.9%
  3. Bill Miller add 2.8%
  4. David Einhorn add 1.1%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Christopher Davis - Davis Selected Advisers 2026 Q2 5.1% Reduce −3.8% 75,232,254 $1.2B history
Glenview Capital Management 2026 Q2 2.9% Add +8.7% 9,877,409 $157M history
David Einhorn - DME Capital Management 2026 Q2 1.1% Add +52.6% 2,773,470 $44M history
Bill Miller - Miller Value Partners 2026 Q2 2.8% Add +0.2% 733,164 $12M history
Kentucky Trust Co. - Kentucky Trust exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 157 $2K history

4 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 12 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Aug 15, 2026 Filing Doc
4 Period Jun 30, 2026 · 2 forms Filing Doc
4 Period Jun 25, 2026 Filing Doc
4 Period Apr 15, 2026 Filing Doc
4 Period Mar 23, 2026 Filing Doc
4 Period Mar 6, 2026 · 7 forms Filing Doc
4 Period Aug 27, 2025 Filing Doc
4 Period Mar 6, 2026 · 10 forms Filing Doc
4 Period Mar 3, 2026 Filing Doc

Updated 3 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $15.39B $14.69B $14.25B
Gross profit $6.44B $5.62B $5.01B
Gross margin * 41.8% 38.3% 35.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $12.98B $9.52B $9.79B
Total non-current assets * $34.71B $31.98B $27.4B
Total assets $47.69B $41.5B $37.19B
Total current liabilities $7.78B $5.78B $7.09B
Total non-current liabilities * $19.44B $17.09B $15.39B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $2.8B $2.3B $2.32B
Cash from investing -$0.764B $1.8B -$0.428B
Cash from financing -$2.3B -$4.33B -$1.29B
Net change in cash -$268.9M -$257.5M $611.9M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders